Role of plants, environmental toxins and physical neurotoxicological factors in Amyotrophic lateral sclerosis, Alzheimer Disease and other Neurodegenerative Diseases
Article Sidebar
Main Article Content
Abstract
Aim of this work is to verify the effect of some neurotoxins, physical factors and geography in presentation of some Relevant Neurological disorder like some form of ASL, PD, AD.
The geographic diffusion of the ASL/PD in west pacific (GUAM foci), and mutation of SOD 1 and other mutations are interesting facts to verify the recent literature about the neurotoxic process.
Related to the references presented a global conclusion about the pathogenetic progression of some neurological disease will be produced as instrument for new hypothesis and for the introduction of new innovative therapeutic strategies.
Article Details
Copyright (c) 2019 Luisetto M, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Escobar-Khondiker M, Höllerhage M, Muriel MP, Champy P, Bach A, et al. Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured neurons. J Neurosci. 2007; 27: 7827-7837. Ref.: https://goo.gl/3cFDm8
N Bonneau, J Le Ven, I Schmitz-Afonso, V Guérineau, I Bajin ba Ndob, et al. Annonaceous acetogenins as environmental neurotoxins: Human exposure from edible Annona fruits. Planta Med. 2012; 78 - PH25. Ref.: https://goo.gl/fdZdir
Lannuzel A, Michel PP, Caparros-Lefebvre D, Abaul J, Hocquemiller R, et al. Toxicity of Annonaceae for dopaminergic neurons: Potential role in atypical parkinsonism in Guadeloupe. Mov Disord. 2002;17: 84-90. Ref.: https://goo.gl/NhQaGs
Höllerhage M, Rösler TW, Berjas M, Luo R, Tran K, et al. Neurotoxicity of Dietary Supplements from Annonaceae Species. Int J Toxicol. 2015; 34: 543-550. Ref.: https://goo.gl/3Dn27B
Zafra-Polo MC, González MC, Estornell E, Sahpaz S, Cortes D. Acetogenins from Annonaceae, inhibitors of mitochondrial complex I. Phytochemistry. 1996; 42: 253-271. Ref.: https://goo.gl/Sdmqi2
P. N'Gouemo, B. Koudogbo, H. Pambou Tchivounda, C. Akono‐Nguema, Minko M. Etoua
Effects of ethanol extract of Annona muricata on pentylenetetrazol‐induced convulsive seizures in mice. Short Communication. 1998. Ref.: https://goo.gl/Dgr8fR
Moghadamtousi SZ, Rouhollahi E, Hajrezaie M, Karimian H, Abdulla MA, et al. Annona muricata leaves accelerate wound healing in rats via involvement of Hsp70 and antioxidant defence. Int J Surg. 2015; 18: 110-117. Ref.: https://goo.gl/S8fkmi
Chen Y, Chen JW, Zhai JH, Wang Y, Wang SL, et al. Antitumor activity and toxicity relationship of annonaceous acetogenins. Food Chem Toxicol. 2013; 58: 394-400. Ref.: https://goo.gl/7jsbTN
Ribeiro Ldo P, Zanardi OZ, Vendramim JD, Yamamoto PT. Comparative toxicity of an acetogenin-based extract and commercial pesticides against citrus red mite. Exp Appl Acarol. 2014; 64: 87-98. Ref.: https://goo.gl/vnpnc7
Levine RA, Richards KM, Tran K, Luo R, Thomas AL, et al. Determination of Neurotoxic Acetogenins in Pawpaw (Asimina triloba) Fruit by LC-HRMS. J Agric Food Chem. 2015; 63: 1053-1056. Ref.: https://goo.gl/WBmX6q
Jiang Z, Wang W, Perry G, Zhu X, Wang X. Mitochondrial dynamic abnormalities in amyotrophic lateral sclerosis. Transl Neurodegener. 2015; 4: 14. Ref.: https://goo.gl/vxJowD
Ravindranath V. Neurolathyrism: mitochondrial dysfunction in excitotoxicity mediated by L-beta-oxalyl aminoalanine. Neurochem Int. 2002; 40: 505-509. Ref.: https://goo.gl/AueXgQ
Potts LF, Luzzio FA, Smith SC, Hetman M, Champy P, et al. Annonacin in Asimina triloba fruit: Implication for neurotoxicity. Neurotoxicology. 2012; 33: 53-58. Ref.: https://goo.gl/qi3SpF
Panov A, Dikalov S, Shalbuyeva N, Taylor G, Sherer T, et al. Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication. J Biol Chem. 2005; 280: 42026-42035. Ref.: https://goo.gl/yYvYvH
Shen WB, McDowell KA, Siebert AA, Clark SM, Dugger NV, et al. Environmental neurotoxin-induced progressive model of parkinsonism in rats. Ann Neurol. 2010; 68: 70-80. Ref.: https://goo.gl/3M1CtV
Scott LL, Downing TG. B-N-Methylamino-l-alanine (BMAA) Toxicity Is Gender and Exposure-Age Dependent in Rats. Toxins (Basel). 2018; 10: 16. Ref.: https://goo.gl/69V7GM
Uversky VN. Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration. Cell Tissue Res. 2004; 318: 225-241. Ref.: https://goo.gl/3Erqvj
de Pedro N, Cautain B, Melguizo A, Vicente F, Genilloud O, Peláez F, et al. Mitochondrial complex I inhibitors, acetogenins, induce HepG2 cell death through the induction of the complete apoptotic mitochondrial pathway. J Bioenerg Biomembr. 2013; 45: 153-164. Ref.: https://goo.gl/YqcVof
Degli Esposti M, Ghelli A, Ratta M, Cortes D, Estornell E. Natural substances (acetogenins) from the family Annonaceae are powerful inhibitors of mitochondrial NADH dehydrogenase (Complex I). Biochem J. 1994; 301: 161-167. Ref.: https://goo.gl/gqXFpE
Segura Aguilar J, Kostrzewa RM. Neurotoxins and neurotoxic species implicated in neurodegeneration. Neurotox Res. 2004; 6: 615-630. Ref.: https://goo.gl/h1K7Sc
Caparros-Lefebvre D, Steele J, Kotake Y, Ohta S. Geographic isolates of atypical Parkinsonism and tauopathy in the tropics: possible synergy of neurotoxins. Mov Disord. 2006; 21: 1769-1771. Ref.: https://goo.gl/twX6pZ
Khandare AL, Kumar RH, Meshram II, Arlappa N, Laxmaiah A, et al. Current scenario of consumption of Lathyrus sativus and lathyrism in three districts of Chhattisgarh State, India. Toxicon. 2018; 150: 228-234. Ref.: https://goo.gl/Kf6kGC
Salama M, Arias-Carrión O. Natural toxins implicated in the development of Parkinson’s disease. Ther Adv Neurol Disord. 2011; 4: 361-373. Ref.: https://goo.gl/fo1KA7
Bozzoni V, Pansarasa O, Diamanti L, Nosari G, Cereda C. Amyotrophic lateral sclerosis and environmental factors. Funct Neurol. 2016; 31: 7-19. Ref.: https://goo.gl/UpPN7K
Pan-Montojo F, Reichmann H. Considerations on the role of environmental toxins in idiopathic Parkinson’s disease pathophysiology. Transl Neurodegener. 2014; 3: 10. Ref.: https://goo.gl/EJ9URY
Rafael H, David JO, Vilca AS. Etiology and treatment of amyotrophic lateral sclerosis. Am J Neurodegener Dis. 2017; 6: 1-8. Ref.: https://goo.gl/rtZ4Ra
Das K, Nag C, Ghosh M. Familial, Environmental, and Occupational Risk Factors in Development of Amyotrophic Lateral Sclerosis. N Am J Med Sci. 2012; 4: 350-355. Ref.: https://goo.gl/s1hzKe
Malek AM, Barchowsky A, Bowser R, Youk A, Talbott EO. Pesticide exposure as a risk factor for amyotrophic lateral sclerosis: a meta-analysis of epidemiological studies: pesticide exposure as a risk factor for ALS. Environ Res. 2012; 117: 112-119. Ref.: https://goo.gl/WU5nH4
Zhou H, Chen G, Chen C, Yu Y, Xu Z. Association between extremely low-frequency electromagnetic fields occupations and amyotrophic lateral sclerosis: a meta-analysis. PLoS One. 2012; 7: e48354. Ref.: https://goo.gl/HfDCt4
Banack SA, Cox PA. Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam. Neurology. 2003; 61: 387-389. Ref.: https://goo.gl/Y6kXf2
Cox PA, Banack SA, Murch SJ. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. Proc Natl Acad Sci U S A. 2003; 100: 13380-13383. Ref.: https://goo.gl/Xm4YVK
Ingre C, Roos PM, Piehl F, Kamel F, Fang F. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015; 7: 181-193. Ref.: https://goo.gl/Lgk4yL
Deng HX, Zhai H, Bigio EH, Yan J, Fecto F, et al. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann Neurol. 2010; 67: 739-748. Ref.: https://goo.gl/v2VJqB
Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med. 2004; 10: S10-S17. Ref.: https://goo.gl/JoNjK7
Huss A, Spoerri A, Egger M, Kromhout H, Vermeulen R, et al. Occupational exposure to magnetic fields and electric shocks and risk of ALS: the Swiss National Cohort. Amyotroph Lateral Scler Frontotemporal Degener. 2015; 16: 80-85. Ref.: https://goo.gl/W5AeYm
Martin S, Al Khleifat A, Al-Chalabi A. What causes amyotrophic lateral sclerosis? F1000Res. 2017; 6: 371. Ref.: https://goo.gl/KJTgiH
Abhinav K, Al-Chalabi A, Hortobagyi T, Leigh PN. Electrical injury and amyotrophic lateral sclerosis: a systematic review of the literature. J Neurol Neurosurg Psychiatry. 2007; 78: 450-453. Ref.: https://goo.gl/8TSPgf
Delzor A, Couratier P, Boumédiène F, Nicol M, Druet-Cabanac M, et al. Searching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programme. BMJ Open. 2014; 4: e005528. Ref.: https://goo.gl/mGcWPh
Henry KA, Fagliano J, Jordan HM, Rechtman L, Kaye WE. Geographic Variation of Amyotrophic Lateral Sclerosis Incidence in New Jersey, 2009–2011. Am J Epidemiol. 2015; 182: 512-519. Ref.: https://goo.gl/mD75DD
Rooney J, Heverin M, Vajda A, Crampsie A, Tobin K, et al. An Exploratory Spatial Analysis of ALS Incidence in Ireland over 17.5 Years (1995 – July 2013). PLoS One. 2014; 9: e96556. Ref.: https://goo.gl/jCeEyt
Logroscino G, Piccininni M. Amyotrophic Lateral Sclerosis Descriptive Epidemiology: The Origin of Geographic Difference. Neuroepidemiology. 2019; 52: 93-103. Ref.: https://goo.gl/2hDwXo
Scott KM, Abhinav K, Stanton BR, Johnston C, Turner MR, et al. Geographical clustering of amyotrophic lateral sclerosis in South-East England: a population study. Neuroepidemiology. 2009; 32: 81-88. Ref.: https://goo.gl/ZrVzPN
Uenal H, Rosenbohm A, Kufeldt J, Weydt P, Goder K, et al. Incidence and Geographical Variation of Amyotrophic Lateral Sclerosis (ALS) in Southern Germany – Completeness of the ALS Registry Swabia. PLoS One. 2014; 9: e93932. Ref.: https://goo.gl/5hjGV4
Kokubo Y, Kuzuhara S, Narita Y. Geographical distribution of amyotrophic lateral sclerosis with neurofibrillary tangles in the Kii Peninsula of Japan. J Neurol. 2000; 247: 850-852. Ref.: https://goo.gl/oqGkV8
Virginia Bozzoni, Orietta Pansarasa, Luca Diamanti, Guido Nosari, Cristina Cereda, et al. Amyotrophic lateral sclerosis and environmental factors. Funct Neurol. 2016; 31: 7-19. Ref.: https://goo.gl/WpMiMG
Yu Y, Su FC, Callaghan BC, Goutman SA, Batterman SA, et al. Environmental Risk Factors and Amyotrophic Lateral Sclerosis (ALS): A Case-Control Study of ALS in Michigan. PLoS One. 2014; 9: e101186. Ref.: https://goo.gl/USCX5B
Kuzuhara S. [ALS-parkinsonism-dementia complex of the Kii peninsula of Japan (Muro disease). Historical review, epidemiology and concept]. Rinsho Shinkeigaku. 2007; 47: 962-965. Ref.: https://goo.gl/dGrJ61
Zarei S, Carr K, Reiley L, Diaz K, Guerra O, et al. A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int. 2015; 6: 171. Ref.: https://goo.gl/WAWsUw
Ludolph AC, Hugon J, Dwivedi MP, Schaumburg HH, Spencer PS. Studies on the aetiology and pathogenesis of motor neuron diseases. 1. Lathyrism: clinical findings in established cases. Brain. 1987; 110: 149-465. Ref.: https://goo.gl/Z7Q7KU
Khandare AL, Babu JJ, Ankulu M, Aparna N, Shirfule A, et al. Grass pea consumption & present scenario of neurolathyrism in Maharashtra State of India. Indian J Med Res. 2014; 140: 96-101. Ref.: https://goo.gl/bW4wgx
Uccelli R, Binazzi A, Altavista P, Belli S, Comba P, et al. Geographic distribution of amyotrophic lateral sclerosis through motor neuron disease mortality data. Eur J Epidemiol. 2007; 22: 781-790. Ref.: https://goo.gl/548yma
Schwartz GG, Rundquist BC, Simon IJ, Swartz SE. Geographic distributions of motor neuron disease mortality and well water use in U.S. counties. Amyotroph Lateral Scler Frontotemporal Degener. 2017; 18: 279-283. Ref.: https://goo.gl/uDefbU
Li W, Lee MH, Henderson L, Tyagi R, Bachani M, et al. Human endogenous retrovirus-K contributes to motor neuron disease. Sci Transl Med. 2015; 7: 307ra153. Ref.: https://goo.gl/FbY7so
Chio A, Calvo A, Dossena M, Ghiglione P, Mutani R, et al. ALS in Italian professional soccer players: the risk is still present and could be soccer-specific. Amyotroph Lateral Scler. 2009; 10: 205-209. Ref.: https://goo.gl/BdqgVD
Chiò A, Benzi G, Dossena M, Mutani R, Mora G. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain. 2005; 128: 472-476. Ref.: https://goo.gl/yz7Ubm
Belli S, Vanacore N. Proportionate mortality of Italian soccer players: is amyotrophic lateral sclerosis an occupational disease? Eur J Epidemiol. 2005; 20: 237-242. Ref.: https://goo.gl/r2Zfg3
Delzor A, Couratier P, Boumédiène F, Nicol M, Druet-Cabanac M, et al. Searching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programme. BMJ Open. 2014; 4: e005528. Ref.: https://goo.gl/RKPkSP
Manzano GM, Giuliano LM, Nóbrega JA. A brief historical note on the classification of nerve fibers Arq Neuropsiquiatr. 2008; 66: 117-119. Ref.: https://goo.gl/8ZcD7C
Tapia R. Cellular and molecular mechanisms of motor neuron death in amyotrophic lateral sclerosis: a perspective. Front Cell Neurosci. 2014; 8: 241. Ref.: https://goo.gl/bLTZqR
Bélanger M, Allaman I, Magistretti PJ. Brain Energy Metabolism: Focus on Astrocyte-Neuron Metabolic Cooperation. Cell Metab. 2011; 14: 724-738. Ref.: https://goo.gl/6WLzWp
Falkowska A, Gutowska I, Goschorska M, Nowacki P, Chlubek D, et al. Energy Metabolism of the Brain, Including the Cooperation between Astrocytes and Neurons, Especially in the Context of Glycogen Metabolism. Int J Mol Sci. 2015; 16: 25959-25981. Ref.: https://goo.gl/smjsmd
Bertamini M, Marzani B, Guarneri R, Guarneri P, Bigini P, et al. Mitochondrial oxidative metabolism in motor neuron degeneration (mnd) mouse central nervous system. Eur J Neurosci. 2002; 16: 2291-2296. Ref.: https://goo.gl/KVDq6F
Tefera TW, Borges K. Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments. Front Neurosci. 2016; 10: 611. Ref.: https://goo.gl/EhcDe5
Belli S, Vanacore N. Proportionate mortality of Italian soccer players: is amyotrophic lateral sclerosis an occupational disease? Eur J Epidemiol. 2005; 20: 237-242. Ref.: https://goo.gl/kMmb95
Malek AM, Barchowsky A, Bowser R, Youk A, Talbott EO. Pesticide exposure as a risk factor for amyotrophic lateral sclerosis: a meta-analysis of epidemiological studies: pesticide exposure as a risk factor for ALS. Environ Res. 2012; 117: 112-119. Ref.: https://goo.gl/bA3Xie
Alessandro Cristani, Elisa Romagnoli. Storia del rapporto tra sclerosi laterale amiotrofica e sport: alla ricerca dell’etiopatogenesi sconosciuta. Recenti Progressi Medicina. 2006. Ref.: https://goo.gl/33y53X
Feddermann-Demont N, Junge A, Weber KP, Weller M, Dvořák J, et al. Prevalence of potential sports‐associated risk factors in Swiss amyotrophic lateral sclerosis patients. Brain Behav. 2017; 7: e00630. Ref.: https://goo.gl/ikToDA
Vargas MI, Gariani J, Sztajzel R, Barnaure-Nachbar I, Delattre BM, et al. Spinal Cord Ischemia: Practical Imaging Tips, Pearls, and Pitfalls. AJNR Am J Neuroradiol. 2015; 36: 825-830. Ref.: https://goo.gl/n8L7zd
Mauro Luisetto , Behzad N-A, Nilesh MM, Ghulam RM, Ram KS, et al. Amyotrophic Lateral Sclerosis and Endogenous-Esogenous Toxicological Movens: New Model to Verify Other Pharmacological Strategies. Arch Pathol Clin Res. 2018; 2: 28-48. Ref.: https://goo.gl/QpkZd6
Kim S, Kim H, Kralik JD, Jeong J. Vulnerability-Based Critical Neurons, Synapses, and Pathways in the Caenorhabditis elegans Connectome. PLoS Comput Biol. 2016; 12: e1005084. Ref.: https://goo.gl/HedD1H
Caller TA, Chipman JW, Field NC, Stommel EW. Spatial analysis of amyotrophic lateral sclerosis in Northern New England, USA, 1997-2009. Muscle Nerve. 2013; 48: 235-241. Ref.: https://goo.gl/cSWyYs
Lee BC, Johng HM, Lim JK, Jeong JH, Baik KY, et al. Effects of extremely low frequency magnetic field on the antioxidant defense system in mouse brain: a chemiluminescence study. J Photochem Photobiol B. 2004; 73: 43-48. Ref.: https://goo.gl/bsRTqj
Piazza O, Sirén AL, Ehrenreich H. Soccer, neurotrauma and amyotrophic lateral sclerosis: is there a connection? Curr Med Res Opin. 2004; 20: 505-508. Ref.: https://goo.gl/X5g9Zd
Scotter EL, Chen HJ, Shaw CE. TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets. Neurotherapeutics. 2015; 12: 352-363. Ref.: https://goo.gl/NkJD6Q
Sweeney P, Park H, Baumann M, Dunlop J, Frydman J, et al. Protein misfolding in neurodegenerative diseases: implications and strategie. Transl Neurodegener. 2017; 6: 6. Ref.: https://goo.gl/4RdYnD